Home About us Current issue Back issues Submission Instructions Advertise Contact Login   

Search Article 
  
Advanced search 
 
Saudi Journal of Kidney Diseases and Transplantation
Users online: 483 Home Bookmark this page Print this page Email this page Small font sizeDefault font size Increase font size 


 
CASE REPORT Table of Contents   
Year : 2019  |  Volume : 30  |  Issue : 2  |  Page : 545-548
Regression of renal angiomyolipomas with oral rapamycin therapy in a patient with tuberous sclerosis complex disease


1 Department of Nephrology, Adana Dr. Turgut Noyan Research and Medical Center, Faculty of Medicine, Baskent University, Adana, Turkey
2 Department of Interventional Radiology, Adana Dr. Turgut Noyan Research and Medical Center, Faculty of Medicine, Baskent University, Adana, Turkey

Correspondence Address:
Dilek Torun
Department of Nephrology, Adana Dr. Turgut Noyan Research and Medical Center, Faculty of Medicine, Baskent University, Adana
Turkey
Login to access the Email id


DOI: 10.4103/1319-2442.256866

PMID: 31031395

Rights and Permissions

We present a case of a 32-year-old female who had been diagnosed tuberous sclerosis complex (TSC) two years ago. In view of serious hemorrhagic complication risk of the selective embolization, we commenced her on oral rapamycin therapy for regression of angiomyolipomas (AMLs). On the 1st year of rapamycin treatment, bilateral renal AMLs were regressed and bilateral selective embolization of the AML was performed after the 1st year of treatment. Rapamycin therapy may regress renal lesions in TSC disease. Therefore, it may increase surgical intervention.


[FULL TEXT] [PDF]*
Print this article  Email this article
    

  Similar in PUBMED
    Search Pubmed for
    Search in Google Scholar for
   Citation Manager
  Access Statistics
   Reader Comments
   Email Alert *
   Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed245    
    Printed4    
    Emailed0    
    PDF Downloaded43    
    Comments [Add]    

Recommend this journal